Goldman Sachs & Co. LLC's Form 4/A amendment
AmendedAttovia Therapeutics, Inc.ATTO · filed Aug 28, 2026
- Accession no.
- 0000886982-26-000522
- Filed
- Aug 28, 2026, 5:38 PM ET
- Trade date
- Aug 5-6, 2026
- Filing delay
- 23 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 13, 2026
This filing lists 27 non-derivative transactions and 8 derivative transactions. Open-market purchases total $10.3M. Open-market sales total $2.25M. It was filed 23 days after the trade.
This amendment replaces 0000886982-26-000495 (filed Aug 13, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldman Sachs & Co. LLCCIK 0000769993 | Other: Former 10% Owner |
| Goldman Sachs Group IncCIK 0000886982 | Other: Former 10% Owner |
| Goldman Sachs Asset Management, L.P.CIK 0001229262 | Other: Former 10% Owner |
| Broad Street Principal Investments, L.L.C.CIK 0001575993 | Other: Former 10% Owner |
| West Street Life Sciences I, L.P.CIK 0001951154 | Other: Former 10% Owner |
| WSLS Emp Offshore Investments, L.P.CIK 0002148329 | Other: Former 10% Owner |
| WSLS Offshore Investments, SLPCIK 0002148330 | Other: Former 10% Owner |
| WSLS Emp Onshore Investments, L.P.CIK 0002148331 | Other: Former 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +85,000 | $21.00 | +$1,785,000 | 85,000 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −988 | $22.03 | −$21,765.64 | 84,012 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −447 | $21.87 | −$9,775.89 | 83,565 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −1,332 | $22.03 | −$29,343.96 | 82,233 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −200 | $22.05 | −$4,410 | 82,033 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −1,556 | $22.06 | −$34,325.36 | 80,477 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −3,402 | $22.02 | −$74,912.04 | 77,075 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −200 | $22.10 | −$4,420 | 76,875 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −480 | $21.55 | −$10,344 | 76,395 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −100 | $22.11 | −$2,211 | 76,295 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −753 | $21.97 | −$16,543.41 | 75,542 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −672 | $22.02 | −$14,797.44 | 74,870 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −6,970 | $22.03 | −$153,549.1 | 67,900 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −400 | $22.02 | −$8,808 | 67,500 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −1,180 | $21.84 | −$25,771.2 | 66,320 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −1,040 | $22.05 | −$22,932 | 65,280 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −300 | $20.84 | −$6,252 | 64,980 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −443 | $21.78 | −$9,648.54 | 64,537 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −200 | $22.05 | −$4,410 | 64,337 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −700 | $22.07 | −$15,449 | 63,637 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −1,163 | $22.19 | −$25,806.97 | 62,474 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −100 | $21.99 | −$2,199 | 62,374 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −6,763 | $21.61 | −$146,148.43 | 55,611 | Indirect | |
| Aug 5, 2026 | Common Stock | SSaleDisposed | −76,418 | $21.04 | −$1,607,834.72 | 0 | Indirect | |
| Aug 6, 2026 | Common Stock | CConversionAcquired | +1,957,134 | $0.00 | $0 | 2,042,134 | Indirect | |
| Aug 6, 2026 | Common Stock | CConversionAcquired | +478,498 | $0.00 | $0 | 2,520,632 | Indirect | |
| Aug 6, 2026 | Common Stock | PPurchaseAcquired | +500,000 | $17.00 | +$8,500,000 | 3,020,632 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | CConversionDisposed | −1,957,134 | $0.00 | $0 | 0 | Indirect | |
| Aug 6, 2026 | Common Stock | CConversionDisposed | −478,598 | $0.00 | $0 | 0 | Indirect | |
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +2,872 | $21.22 | +$60,943.84 | 2,872 | Indirect | |
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +28,717 | $21.22 | +$609,374.74 | 31,589 | Indirect | |
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +11,488 | $21.22 | +$243,775.36 | 43,077 | Indirect | |
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +45,588 | $21.27 | +$969,656.76 | 88,665 | Indirect | |
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +11,398 | $21.27 | +$242,435.46 | 100,063 | Indirect | |
| Aug 5, 2026 | Common Stock | PPurchaseAcquired | +5,744 | $21.22 | +$121,887.68 | 105,807 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
- F2
These transactions in or with respect to the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.
- F3
GS&Co's transactions in or with respect to the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares, sales of a total of 105,807 shares, and establishment of long equity swap positions with respect to a total of 105,807 shares. The equity swap positions were inadvertently omitted from the Reporting Persons' original Form 4.
- F4
The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.
- F5
All shares of the Issuer's redeemable convertible preferred stock automatically converted into shares of the Issuer's common stock on a 1-for-1 basis, adjusted for a 1-for-9.29 reverse stock split effected by the Issuer on July 29, 2026, upon the completion of the Issuer's initial public offering (the "IPO").
- F6
This statement is being filed by Goldman Sachs Group, Inc. ("GS Group"), GS&Co, Goldman Sachs Asset Management, L.P. ("GSAM LP"), Broad Street Principal Investments L.L.C. ("BSPI"), which directly holds 96,190 shares of common stock purchased in the IPO and 468,565 shares of common stock converted from 3,497,806 shares of Series B Preferred Stock and 855,179 shares of Series C Preferred Stock, WSLS Offshore Investments, SLP ("WSLS Offshore"), which directly holds 131,283 shares of common stock purchased in the IPO and 639,518 shares of common stock converted from 4,773,948 shares of Series B Preferred Stock and 1,167,182 shares of Series C Preferred Stock, West Street Life Sciences I, L.P. ("WSLS I"), which directly holds 137,708 shares of common stock purchased in the IPO and 670,812 shares of common stock converted from 5,007,564 shares of Series B Preferred Stock and 1,224,299 shares of Series C Preferred Stock,... (continued in footnote 7)
- F7
(continued from footnote 6)...WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore"), which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock converted from 1,342,794 shares of Series B Preferred Stock and 328,300 shares of Series C Preferred Stock, and WSLS Emp Onshore Investments, L.P. ("WSLS Emp Onshore"), which directly holds 97,892 shares of common stock purchased in the IPO and 476,858 shares of common stock converted from 3,559,718 shares of Series B Preferred Stock and 870,315 shares of Series C Preferred Stock. GS&Co is a direct subsidiary of GS Group and is the manager of BSPI. WSLS Offshore, WSLS I, WSLS Emp Offshore, and WSLS Emp Onshore are investment vehicles managed by GSAM LP, an indirect subsidiary of GS Group.